Hypoxia stimulates p16 expression and association with cdk4

被引:20
|
作者
Zygmunt, A [1 ]
Tedesco, VC [1 ]
Udho, E [1 ]
Krucher, NA [1 ]
机构
[1] Pace Univ, Dept Biol Sci, Pleasantville, NY 10570 USA
关键词
hypoxia; p16; cdk4; pRb;
D O I
10.1006/excr.2002.5564
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Exposure of CV-1P cells to hypoxic conditions causes cell proliferation inhibition concomitant with the accumulation of pRb in the hypophosphorylated, growth suppressive form. This is in part due to inhibition of pRb-directed cdk4 and cdk2 activity. In this study we attempted to elucidate the mechanism by which cdk4 is inactivated under hypoxic conditions. After 18 h of hypoxia, CV-1P cells are inhibited from progressing from G, phase into the S phase of the cell cycle. This occurs in conjunction with dephosphorylation of serine-795, which is a putative substrate of cdk4. The amounts of cdk4, cdk6, and the D type cyclins are not affected by 18 h of hypoxia. The levels of cdki p16, p18, p19, and p57 under aerobic or hypoxic conditions were analyzed and although the levels of most cdki are unaffected by hypoxic conditions, the level of p16 increases significantly by 18 h of hypoxia. The mechanism by which cdk4 activity is inhibited under hypoxic conditions may be mediated through p16 association with cdk4. Immunoprecipitation analysis shows that p16 binds to cdk4 under hypoxic conditions but does not in cells maintained under aerobic conditions. Thus p16 may be involved in hypoxia-induced growth inhibition. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:53 / 60
页数:8
相关论文
共 50 条
  • [31] P16 methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib
    Li, Paiyun
    Zhang, Xuehong
    Gu, Liankun
    Zhou, Jing
    Deng, Dajun
    PLOS ONE, 2019, 14 (10):
  • [32] Identification of CDK4 sequences involved in cyclin D1 and p16 binding
    Coleman, KG
    Wautlet, BS
    Morrissey, D
    Mulheron, J
    Sedman, SA
    Brinkley, P
    Price, S
    Webster, KR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18869 - 18874
  • [33] Alterations of CDK4 and P16, control elements of the cell cycle, in Alzheimer disease.
    McShea, A
    Harris, PLR
    Webster, K
    Wahl, A
    Smith, MA
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (05): : 85 - 85
  • [34] CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component
    Guiyan Xu
    Jian Yi Li
    Journal of Neuro-Oncology, 2018, 136 : 445 - 452
  • [35] P16 PROTEINS FROM MELANOMA-PRONE FAMILIES ARE DEFICIENT IN BINDING TO CDK4
    REYMOND, A
    BRENT, R
    ONCOGENE, 1995, 11 (06) : 1173 - 1178
  • [36] A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers
    Kong, LF
    Ying, PZ
    Liu, ZG
    Gen, JH
    Zhao, YW
    CANCER LETTERS, 1998, 130 (1-2) : 93 - 101
  • [37] IDENTIFICATION OF HUMAN AND MOUSE P19, A NOVEL CDK4 AND CDK6 INHIBITOR WITH HOMOLOGY TO P16(INK4)
    CHAN, FKM
    ZHANG, JK
    CHENG, L
    SHAPIRO, DN
    WINOTO, A
    MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (05) : 2682 - 2688
  • [38] Simulation of Different Truncated p16(INK4a) Forms and In Silico Study of Interaction with Cdk4
    Fahham, Najmeh
    Ghahremani, Mohammad Hossein
    Sardari, Soroush
    Vaziri, Behrouz
    Ostad, Seyed Nasser
    CANCER INFORMATICS, 2009, 7 : 1 - 11
  • [39] Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence
    Ian C Talbot
    World Journal of Gastroenterology, 2006, (39) : 6391 - 6396
  • [40] CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck
    Billard-Sandu, Camelia
    Tao, Yun-Gan
    Sablin, Marie-Paule
    Dumitrescu, Gabriela
    Billard, David
    Deutsch, Eric
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (05) : 1273 - 1280